Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults - Wikidata - wikimedia - TriplyDB

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

http://www.wikidata.org/entity/Q24200879

about

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults Interventions to increase tuberculosis case detection at primary healthcare or community level services Urine lateral flow lipoarabinomannan assay for diagnosing active tuberculosis in adults living with HIV Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment Pulmonary Tuberculosis Diagnosis: Where We Are?Screening strategies for active tuberculosis: focus on cost-effectiveness The implications of whole-genome sequencing in the control of tuberculosis Accuracy of the Bronchoalveolar Lavage Enzyme-Linked Immunospot Assay for the Diagnosis of Pulmonary Tuberculosis: A Meta-analysis Diagnostics for pulmonary tuberculosis Diagnostic Performance of Xpert MTB/RIF in Tuberculous Pleural Effusion: Systematic Review and Meta-analysis Recent developments in the diagnosis and management of tuberculosis.Laboratory Diagnosis of Mycobacterium tuberculosis Infection and Disease in Children Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015)The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape Province The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis Are current case-finding methods under-diagnosing tuberculosis among women in Myanmar? An analysis of operational data from Yangon and the nationwide prevalence survey Rapid infectious diseases diagnostics using Smartphones.Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus.Diagnostic accuracy of nucleic acid amplification tests (NAATs) in urine for genitourinary tuberculosis: a systematic review and meta-analysis.An evaluation of automated chest radiography reading software for tuberculosis screening among public- and private-sector patients.Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis.Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.Performance evaluation of the Xpert MTB/RIF assay according to its clinical application.IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatment Choosing algorithms for TB screening: a modelling study to compare yield, predictive value and diagnostic burden Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial Reply to "molecular diagnosis of rifampin-monoresistant tuberculosis in Indian patients: problems with a discordance analysis"

P2860

Q24185754-1F446FC5-6DF7-4239-BAC9-342DD266440D Q24187036-5B340F84-9E75-4FCE-ACEC-25F2F9AB32A6 Q24187533-C08EBC8C-6F54-461C-8143-1B6FFF79D93C Q24187942-A1258AE9-09FE-4DF8-998B-A628C93D886A Q26739001-DFE61CE0-A590-4465-B909-24B483C28130 Q26740226-8A2C712F-4B5C-4F91-8716-35253BD43A6B Q26749040-70DED217-BFAC-4194-9C77-DA44D4085FDA Q26750756-DAAD5423-A72F-4B15-8FF8-D1B8569D33EE Q26752633-51FED3F5-8AA0-4382-9ABA-83B51EF0A327 Q28069359-C9603634-EEDB-48F8-A5DF-7814152E6305 Q28077124-272F3DBE-12EC-426B-99D0-E3359DE473BE Q28077210-41FAF16C-0187-447E-99B3-8036BF523239 Q28542588-C4FF4B1C-6D15-4B66-87EB-98B3CE44E31E Q28546035-86204CD1-4564-4F01-8902-A160DD2693D4 Q28546611-1AE858F1-E7C1-498B-8B3F-704771A4705E Q28546789-DC78187E-DAA8-4F97-A228-E43CA2A27FD5 Q28547525-7BB85D77-D527-4ACB-9198-B27AF7F325E8 Q28548369-80B97026-5498-4FA8-9440-F7E5085337A8 Q28555235-9986CE3D-19F9-42FE-B8CA-634E25D0DA7B Q29247880-91ACB491-E36E-4630-9ED0-BF5F2D2ACD65 Q30244102-190F5E95-0FE0-4DAD-ACDE-9111E2E28459 Q31052719-BC894E9C-060C-43C8-9DEC-080FD64CAA94 Q33445523-4E835F87-B88E-413C-A4C3-BB97D90EB389 Q33629698-62726CDA-5AD1-4C55-A805-67B8EFE81619 Q33703605-DE4FEBAF-4B57-4BB0-B46F-359129195447 Q33732298-D41A1019-F730-459F-8B26-108F6995094E Q33767720-72D7332D-DE58-441B-9EF4-2C6B497B1CED Q33768767-ABE4E804-1CEE-4D9F-B648-B6B7ADCADA51 Q33777533-599E252E-DF85-47D6-99EB-0BB7CFB3822A Q33808388-E069AA4C-8FE0-48AC-A88F-2430BD93CC65 Q33820680-35D7FF84-615F-4CB4-9963-C4C7AC6E0AF2 Q33884141-66E33626-375F-47D6-A9FB-34EF6F1B39CF Q34101335-4FF244ED-86BD-46C3-9E0A-CB8D64C57B50 Q34208001-63131748-314D-44CB-AA5E-6EC1FF11F607 Q34480176-2BCDDD30-3072-495B-B9EF-04F05AF371DB Q34584703-CA0F16CC-B42A-472C-BF3C-00F5C4B3E0D9 Q34593096-9CCE8E5C-0042-4D23-A406-66CBDC8AD274 Q34873402-4B0C2C6E-7229-48A8-B1AD-52BD01765DEB Q34974595-6BF2E0D2-4900-4C36-BE3E-0EC617572AD3 Q35035902-312FA8FB-0B61-44B5-BC39-C54D39813847

P2860

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

http://www.wikidata.org/entity/Q24200879

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@ast

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@en

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@en-gb

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@nl

type

label

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@ast

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@en

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@en-gb

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@nl

prefLabel

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@ast

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@en

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@en-gb

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@nl

P1433

Q24200879-72D6C2B8-0582-4A5B-B726-F0B595DECC18

P1476

Q24200879-2C337A6E-EEF7-47FC-9E3A-8195AD643AA9

P2093

Q24200879-439B34B4-850F-42D7-962E-64119EB4024E

Q24200879-90C0677E-9398-4C42-AA98-C48B2CD76D98

Q24200879-ABD59697-7AE0-4F72-BFDB-33BD348E0B56

Q24200879-B86C3267-55D3-4DD9-B417-859BD4A27A30

Q24200879-FBCE9E2B-2CF0-482B-A086-DB5824C91FF7

P275

Q24200879-1BD6AF13-588E-44E1-A171-8DEE8768729F

Q24200879-AAA773CF-EC90-45BE-9DBA-736EA409ED41

P2860

Q24200879-010EC31A-812A-4E3F-B287-7105B5B0C4EC

Q24200879-091CD9A5-2998-40B7-9992-3E9D089FA4B7

Q24200879-0BF8127B-A849-47CE-AB01-DE4D64E53404

Q24200879-0FF93B7B-7821-42F5-88FB-84821B92DDBB

Q24200879-14FACD96-732F-4F9E-9B9F-501E225CED36

Q24200879-16661EC3-BF65-4EEA-870F-6CE4F46F6742

Q24200879-16831915-677D-42C2-B3B3-9F40C4A5B38E

Q24200879-1B0D2555-A1B3-422A-A5DE-8B7FDD38BD26

Q24200879-1E6361C2-DA60-4A82-9F10-DF59B74C19EF

Q24200879-220C57B5-AE99-463E-B2FD-F926CC55B7D3

P304

Q24200879-D09080E9-6A6B-48D0-859A-2040E14236B2

P31

Q24200879-11A61FB9-E08C-4782-92DF-26C4ABE47F67

Q24200879-21B9EFBC-1CEC-41BA-950E-0154CEF514A4

Q24200879-b7faba79-4c37-474c-a3aa-10c04377a309

P3181

Q24200879-6107CBB3-62C8-4654-B622-00C82BFE2D1E

P356

Q24200879-77BAD2B5-00F9-4F32-A69D-87BE985DC194

P407

Q24200879-AD27E0D8-4343-490F-BCC3-7F52456CEC29

P433

Q24200879-05B0D231-38EC-4FB2-9379-CDA93CA276E1

P478

Q24200879-F1FC7806-FE22-4DA9-AFC5-751CE1643B58

P50

Q24200879-5C2C4CC0-5BC2-4E4D-A693-75F5220333BD

Q24200879-DDFB5FA8-415A-4998-A8D1-7DD635C80E30

P5008

Q24200879-8D73A44F-53CE-4029-AD07-DCF1EDD29B37

P577

Q24200879-27600C85-07B8-4090-9D6A-A82A0225B705

P698

Q24200879-05AD1A82-FDDC-4AEE-AF84-A4A5901F81F0

P921

Q24200879-155DB87A-AF9A-4D27-B2BA-5E70588DBED8

Q24200879-17403607-189A-44B9-92D0-527483D6ADBB

Q24200879-36440268-C3FE-4CE5-81DA-53ED9337B565

Q24200879-51A45925-858A-420C-8318-3A623D3CD3A2

Q24200879-77B6F4F4-8E34-4308-A5C1-6D59206433E1

Q24200879-8ADBBFB2-08A2-48D5-876D-D6B607F177C4

Q24200879-C0392F89-D892-4216-86CD-AE586C13F3A9

P932

Q24200879-C37A2ABC-162F-49C0-BDDB-4219D37C6F72

P3181

P356

14651858.CD009593.PUB3

P1433

Cochrane Database of Systematic Reviews

P1476

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

@en

P2093

Catharina C Boehme

http://www.w3.org/2001/XMLSchema#string

David J Horne

http://www.w3.org/2001/XMLSchema#string

Ian Schiller

http://www.w3.org/2001/XMLSchema#string

Madhukar Pai

http://www.w3.org/2001/XMLSchema#string

Nandini Dendukuri

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

No role for quality scores in systematic reviews of diagnostic accuracy studies

In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression.

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

Clinical research and development of tuberculosis diagnostics: moving from silos to synergy

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

P304

CD009593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

333804

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD009593.PUB3

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Nandini Dendukuri

Karen R Steingart

P5008

P577

2014-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24448973

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

pulmonary tuberculosis

heterocyclic compound

polycyclic compound

physiological phenomena

biomedical investigative technique

P932

4470349

http://www.w3.org/2001/XMLSchema#string